Top Pharma Vs. Major Biotech Who is Biopharma’s Favorite Alliance Partner?

Evolving Deal Terms
Mark Edwards Mark Edwards

Orphan Drug Alliances

Alliance Trends
Mark Edwards Mark Edwards

Co-Promotion in Biopharma Agreements Success is in the Details

Evolving Deal Terms
Mark Edwards Mark Edwards

Trends in University Licenses How Healthy is the Seed Corn?

Alliance Trends
Mark Edwards Mark Edwards

The BioPharma Industry in 2015 As Good as it Gets

Biofinancing
Mark Edwards Mark Edwards

Duration of Royalty Obligations ’Til Death Do Us Part?

Alliance Trends
Mark Edwards Mark Edwards

Reā€emergence of Platform Technologies Gonna Party Like It’s 1999

Evolving Deal Terms
Mark Edwards Mark Edwards

2014 Year in Review IPOs, Financings & Alliances

Biofinancing
Mark Edwards Mark Edwards

Sales Milestones Bridging the Valuation Gap

Alliance Trends
Mark Edwards Mark Edwards

Demand Dividend A New Investment Vehicle for Financing Biotech Companies

Biofinancing
Mark Edwards Mark Edwards

Biotech IPOs Springboard for Success

Biofinancing
Mark Edwards Mark Edwards

Biotech Sell Side Research A Retrospective Analysis

Sell-Side Analysis
Mark Edwards Mark Edwards